和铂医药控股有限公司于2026年4月9日披露截至2026年3月31日的股份变动月报表，报告期内公司授权股本维持不变，面值为每股USD 0.000025，共计20,000,000,000股，注册股本总额为USD 500,000。
报告期内，公司已发行股份（不含库存股份）由上月的869,591,522股增至869,850,522股，增幅259,000股。库存股份保持在25,937,000股不变，因此公司本月末已发行股份总数为895,787,522股。
本月增发主要源于首次公开发售后购股权计划的行使，行使数量为259,000股。另据公告，公司于2024年6月6日购回406,000股股份，但尚未办理注销程序。
公司确认，报告期内的所有股份发行和购回活动均遵守香港联交所《上市规则》及法律法规的相关要求。本次月报表由执行董事王劲松签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.